Donald R VanDevanter

8PUBLICATIONS
6CO-AUTHORS
PharmacogenomicsInfant and child healthDisease surveillancePsycholinguistics (incl. speech production and comprehension)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 22, 2022
The Pitfalls of Polypharmacy and Precision Medicine in Cystic Fibrosis.

Donald R VanDevanter, John J LiPuma

|Aug 13, 2021
Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis.

J Stuart Elborn, Patrick A Flume, Donald R Van Devanter

|Jan 12, 2021
Epidemiologic Study of Cystic Fibrosis: 25 years of observational research.

Michael W Konstan, David J Pasta, Donald R VanDevanter

|Nov 21, 2019
Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.

Jeffrey S Wagener, Donald R VanDevanter, Michael W Konstan

|Jan 10, 2018
Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis.

Michael W Konstan, Donald R VanDevanter, Gregory S Sawicki

|Oct 25, 2017
Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change.

Donald R VanDevanter, Marcia L Craib, David J Pasta

Pageof 2

Frequent Collaborators

4 joint publications

Michael W Konstan

3 joint publications

Wayne J Morgan

3 joint publications

David J Pasta

1 joint publications

J Stuart Elborn